Table 3.
Monoclonal antibody especially for breast cancer
| Drug | Mechanism | Type | Therapy Group | Side effects | FDA Approval | REF. |
|---|---|---|---|---|---|---|
| Pertuzumab | HER2/neu | Humanized monoclonal antibody | Metastatic HER2-positive breast cancer | Risk of infection, Bruising and bleeding, Anemia, Diarrhea, Loss of appetite, Sore mouth | Yes | [244] |
| Trastuzumab | HER2/neu | Humanized monoclonal antibody | breast cancer and stomach cancer | flu-like symptoms (high temperature, chills, and mild pain), nausea, and diarrhea | Yes | [245] |